跳至主要内容
临床试验/NCT00800904
NCT00800904已完成不适用

Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,210 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,210
试验地点
1
主要终点
Asthma control test

研究概览

简要总结

The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Established persistent asthma
  • Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer

排除标准

  • Currently participating or have participated in a study with an investigational compound within the last 30 days
  • Current diagnosis of chronic obstructive pulmonary disease (COPD)
  • Smoked more than 10 packs a year

结局指标

主要结局

Asthma control test

时间窗: On the survey date

次要结局

  • Asthma control in mild, moderate and severe persistent asthma patients(On the survey date)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验